News
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
E-bike battery malfunction leads to fire and first NYC battery-related death in 2025, trapping 76-year-old woman in a Queens pizzeria.
A missing elderly woman with dementia has been found deceased in Daviess County. Lola Davis, 89, of Mt. Vernon, Indiana, went ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results